Nusinersen for treating children and young people up to 17 years old with spinal muscular atrophy, Policy Position Statement (PPS191), August 2025.pdf (PDF, 485Kb)
Selective Dorsal Rhizotomy (SDR) for the treatment of spasticity in cerebral palsy in children aged 3-9 years, Policy Position Statement (PP245), March 2024.pdf (PDF, 975Kb)
Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome in people 6-17 years of age, Policy Position Statement (PPS298), April 2025.pdf (PDF, 406Kb)
Tofacitinib for treating juvenile idiopathic arthritis in people from 2 years old up to their 16th birthday, Policy Position Statement (PP229), May 2022.pdf (PDF, 311Kb)